Characterization of Krüppel-like factor 3 expression in T lymphocytes in septic mice

Author:

Yan Miao1,Chi Dongxuan1,Wang Wen1,Pei Pei1,Xie Min1,Li Shuangling1

Affiliation:

1. Peking University First Hospital

Abstract

Abstract Background Krüppel-like factor 3 (KLF3) may be involved in the regulation of inflammatory responses and lymphocyte function. Moreover, immune dysfunction in sepsis involves both hyperinflammatory responses and immunosuppression. However, studies on T-lymphocyte KLF3 expression characteristics in sepsis are lacking. Methods We induced sepsis in mice through cecal ligation and puncture (CLP) and evaluated their survival rate over 7 days. To identify the immune status of the septic mice, we assessed their cytokine levels, organ damage scores, and splenic T-lymphocyte phenotype. Finally, KLF3 expression in T lymphocytes was detected through flow cytometry. Results Over the 7 days of observation, septic mice demonstrated 64.7% mortality. In the early stages after CLP, the proinflammatory and anti-inflammatory cytokine levels increased rapidly, multiple organ damage occurred, and splenic T lymphocytes became activated (with an increase in the proportions of CD69+ cells and mean fluorescence intensity for CD71). However, the proportion of KLF3+ T lymphocytes decreased. Subsequently, cytokine levels and lymphocyte activation decreased. An increase in cell apoptosis led to a substantial loss of T lymphocytes. Considering the continual elevations in serum interleukin 10 and interleukin 6 levels and worsening severe organ damage, the septic mice may have entered a state of chronic inflammation and immunosuppression, with a simultaneous increase in KLF3 expression in T lymphocytes, in the later stages after CLP. Conclusions In septic mice, T-lymphocyte KLF3 expression decreased in the early stage after CLP (i.e., systemic inflammatory response and T-lymphocyte activation stage) but increased in the later stage (i.e., chronic inflammation and immunosuppression stage). As such, KLF3 may be a promising target for dynamic immune monitoring and immunomodulatory therapy for sepsis.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3